153 related articles for article (PubMed ID: 26427383)
1. Significance of Lipolytic Enzymes in Pathogenesis and Treatment of Neglected Diseases.
Chakravorty D; Patra S
Curr Protein Pept Sci; 2016; 17(3):228-42. PubMed ID: 26427383
[TBL] [Abstract][Full Text] [Related]
2. Overcoming the challenges of drug discovery for neglected tropical diseases: the A·WOL experience.
Johnston KL; Ford L; Taylor MJ
J Biomol Screen; 2014 Mar; 19(3):335-43. PubMed ID: 24241712
[TBL] [Abstract][Full Text] [Related]
3. Multi-Target Drugs for Neglected Diseases.
Scotti L; Filho FJ; de Moura RO; Ribeiro FF; Ishiki H; da Silva MS; Filho JM; Scotti MT
Curr Pharm Des; 2016 May; 22(21):3135-63. PubMed ID: 26907943
[TBL] [Abstract][Full Text] [Related]
4. Yeast-based high-throughput screens for discovery of kinase inhibitors for neglected diseases.
Tavella TA; Cassiano GC; Costa FTM; Sunnerhagen P; Bilsland E
Adv Protein Chem Struct Biol; 2021; 124():275-309. PubMed ID: 33632468
[TBL] [Abstract][Full Text] [Related]
5. Modern Approaches for the Discovery of Anti-Infectious Drugs for the Treatment of Neglected Diseases.
Bellera CL; Sbaraglini ML; Talevi A
Curr Top Med Chem; 2018; 18(5):369-381. PubMed ID: 29741140
[TBL] [Abstract][Full Text] [Related]
6. Purinergic receptors and neglected tropical diseases: why ignore purinergic signaling in the search for new molecular targets?
Pacheco PAF; Dantas LP; Ferreira LGB; Faria RX
J Bioenerg Biomembr; 2018 Aug; 50(4):307-313. PubMed ID: 29882206
[TBL] [Abstract][Full Text] [Related]
7. Target-based molecular modeling strategies for schistosomiasis drug discovery.
Ferreira LG; Oliva G; Andricopulo AD
Future Med Chem; 2015; 7(6):753-64. PubMed ID: 25996068
[TBL] [Abstract][Full Text] [Related]
8. Fostering innovative product development for neglected tropical diseases through partnerships.
Starr A; Graef KM; Dent J
Pharm Pat Anal; 2016 Sep; 5(6):391-400. PubMed ID: 27813447
[TBL] [Abstract][Full Text] [Related]
9. Drugs for neglected diseases: part II.
Kaneko T
Future Med Chem; 2011 Sep; 3(11):1329-30. PubMed ID: 21879837
[No Abstract] [Full Text] [Related]
10. In silico repositioning of approved drugs for rare and neglected diseases.
Ekins S; Williams AJ; Krasowski MD; Freundlich JS
Drug Discov Today; 2011 Apr; 16(7-8):298-310. PubMed ID: 21376136
[TBL] [Abstract][Full Text] [Related]
11. Chemogenomics and bioinformatics approaches for prioritizing kinases as drug targets for neglected tropical diseases.
Borba JVVB; Silva AC; Lima MNN; Mendonca SS; Furnham N; Costa FTM; Andrade CH
Adv Protein Chem Struct Biol; 2021; 124():187-223. PubMed ID: 33632465
[TBL] [Abstract][Full Text] [Related]
12. Yeast as a potential vehicle for neglected tropical disease drug discovery.
Denny PW; Steel PG
J Biomol Screen; 2015 Jan; 20(1):56-63. PubMed ID: 25121554
[TBL] [Abstract][Full Text] [Related]
13. Repurposing strategies for tropical disease drug discovery.
Klug DM; Gelb MH; Pollastri MP
Bioorg Med Chem Lett; 2016 Jun; 26(11):2569-76. PubMed ID: 27080183
[TBL] [Abstract][Full Text] [Related]
14. Neglected tropical disease research: rethinking the drug discovery model.
Bombelles T; Coaker H
Future Med Chem; 2015; 7(6):693-700. PubMed ID: 25996062
[No Abstract] [Full Text] [Related]
15. Repurposing of Human Kinase Inhibitors in Neglected Protozoan Diseases.
Dichiara M; Marrazzo A; Prezzavento O; Collina S; Rescifina A; Amata E
ChemMedChem; 2017 Aug; 12(16):1235-1253. PubMed ID: 28590590
[TBL] [Abstract][Full Text] [Related]
16. [Not Available].
Marek M; Shaik TB; Jung M; Sippl W; Pierce RJ; Romier C
Biol Aujourdhui; 2016; 210(4):311-320. PubMed ID: 28327287
[TBL] [Abstract][Full Text] [Related]
17. Screening the Medicines for Malaria Venture Pathogen Box across Multiple Pathogens Reclassifies Starting Points for Open-Source Drug Discovery.
Duffy S; Sykes ML; Jones AJ; Shelper TB; Simpson M; Lang R; Poulsen SA; Sleebs BE; Avery VM
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28674055
[TBL] [Abstract][Full Text] [Related]
18. Finding new hits in neglected disease projects: target or phenotypic based screening?
Gilbert IH; Leroy D; Frearson JA
Curr Top Med Chem; 2011; 11(10):1284-91. PubMed ID: 21401505
[TBL] [Abstract][Full Text] [Related]
19. [Current Trend of Drug Development for Neglected Tropical Diseases (NTDs)].
Kita K
Yakugaku Zasshi; 2016; 136(2):205-11. PubMed ID: 26831795
[TBL] [Abstract][Full Text] [Related]
20. The importance of patent sharing in neglected disease drug discovery.
Edlin C
Future Med Chem; 2011 Sep; 3(11):1331-4. PubMed ID: 21879838
[No Abstract] [Full Text] [Related]
[Next] [New Search]
